Page last updated: 2024-08-24

valsartan and Coronary Restenosis

valsartan has been researched along with Coronary Restenosis in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (72.73)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Chen, YH; Lai, HC; Lee, WL; Liu, TJ1
Koehler, B; Peters, S; Rählert-Sommer, A; Selbig, D; Steffen, H; Trümmel, M1
Dohi, Y; Fujii, T; Hayashi, Y; Ishibashi, K; Kihara, Y; Kurisu, S; Okada, T; Okimoto, T; Otsuka, M; Tadehara, F; Yamamoto, H1
Sato, H1
Wilensky, RL1
Koehler, B; Meyners, W; Peters, S; Trümmel, M; Westermann, K1
Chen, H; Ding, RJ; Jia, SQ; Li, GH; Li, HW; Wang, L; Yao, DK; Zhao, L2
Imaizumi, S; Iwata, A; Kiya, Y; Kumagai, K; Matsuo, K; Miura, S; Nishikawa, H; Saku, K; Shimomura, H; Shirai, K; Zhang, B1
Peters, S1

Reviews

2 review(s) available for valsartan and Coronary Restenosis

ArticleYear
[Acute myocardial infarction].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:10

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Coronary Restenosis; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan

2002
Angiotensin-receptor blockers: revival of the systemic prevention of restenosis?
    Cardiovascular drugs and therapy, 2003, Volume: 17, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Coronary Restenosis; Humans; Receptors, Angiotensin; Stents; Tetrazoles; Valine; Valsartan

2003

Trials

3 trial(s) available for valsartan and Coronary Restenosis

ArticleYear
Beneficial effects of valsartan on target lesion revascularization after percutaneous coronary interventions with bare-metal stents.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:7

    Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Coronary Artery Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Endpoint Determination; Female; Follow-Up Studies; Humans; Japan; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Prospective Studies; Stents; Tetrazoles; Treatment Outcome; Valine; Valsartan

2011
Do valsartan and losartan have the same effects in the treatment of coronary artery disease?
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:1

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Humans; Intercellular Adhesion Molecule-1; L-Selectin; Losartan; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan

2007
Comparison of efficacy of low- (80 mg/day) and high- (160-320 mg/day) dose valsartan in the prevention of in-stent restenosis after implantation of bare-metal stents in type B2/C coronary artery lesions.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2008, Volume: 8, Issue:2

    Topics: Administration, Oral; Aged; Angiotensin II Type 1 Receptor Blockers; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Sex Factors; Stents; Tetrazoles; Valine; Valsartan

2008

Other Studies

6 other study(ies) available for valsartan and Coronary Restenosis

ArticleYear
Iatrogenic Takotsubo Cardiomyopathy Following Overdose Norepinephrine Administration During Percutaneous Coronary Intervention.
    International heart journal, 2020, Nov-28, Volume: 61, Issue:6

    Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Bisoprolol; Coronary Restenosis; Creatine Kinase; Creatine Kinase, MB Form; Drug Overdose; Drug-Eluting Stents; Echocardiography; Humans; Hypotension; Iatrogenic Disease; Intra-Aortic Balloon Pumping; Intraoperative Complications; Male; Medication Errors; Middle Aged; Norepinephrine; Percutaneous Coronary Intervention; Recovery of Function; Shock, Cardiogenic; Stents; Stroke Volume; Takotsubo Cardiomyopathy; Troponin I; Valsartan; Vasoconstrictor Agents

2020
Late lumen loss and follow-up percent diameter stenosis at different doses of oral valsartan six months after bare-metal stent implantation in type B2/C coronary lesions.
    International journal of cardiology, 2010, Jun-25, Volume: 142, Issue:1

    Topics: Administration, Oral; Aged; Cohort Studies; Coronary Restenosis; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Postoperative Complications; Stents; Tetrazoles; Time Factors; Valine; Valsartan

2010
[Coronary stenting. Does AT-1 blocker protect from restenosis?].
    MMW Fortschritte der Medizin, 2003, Nov-13, Volume: 145, Issue:46

    Topics: Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Controlled Clinical Trials as Topic; Coronary Restenosis; Humans; Placebos; Stents; Tetrazoles; Valine; Valsartan

2003
Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial.
    International journal of cardiology, 2005, Feb-15, Volume: 98, Issue:2

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Coronary Restenosis; Coronary Stenosis; Female; Humans; Male; Middle Aged; Stents; Tetrazoles; Valine; Valsartan

2005
Effect of valsartan-eluting stents on the expression of angiotensin II type 2 receptor.
    Chinese medical journal, 2006, Apr-05, Volume: 119, Issue:7

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Immunohistochemistry; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; Stents; Tetrazoles; Valine; Valsartan

2006
[Valsartan eluting-stents inhibited neointimal hyperplasia by decreasing collagen deposition in rabbits].
    Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:5

    Topics: Animals; Collagen; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Hyperplasia; Male; Rabbits; Tetrazoles; Tunica Intima; Valine; Valsartan

2006